Red Flags Detected

  • Going Concern (new) — Company discloses substantial doubt about its ability to continue as a going concern due to financial condition and funding needs.
NASDAQ: RNAZ Transcode Therapeutics, Inc. 8-K

TransCode discloses Phase 1a trial results for TTX-MC138 amid going concern warning

Filed June 3, 2026 · Period ending June 3, 2026 · ~1 min read

2 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade RNAZ commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Feedback
View original filing on SEC.gov

Generated by AI · Jun 3, 2026 3:08 PM